Biomarkers of RUNX1-RT Patients: Inherited Thrombocytipenia and Malignancy Risk
Inés Prieto Remón, Business Line Manager – Haemostasis en Sysmex Iberia shared an insightful post on LinkedIn:
”Reduced GPIa levels and impaired collagen-induced aggregation may serve as diagnostic biomarkers of RUNX1-RT patients.”
Read the article here.
Article: Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk
Authors: Ana Marín-Quílez, Ana Sánchez-Fuentes, Ana Zamora-Cánovas, Pedro Luis Gómez-González, Lorena Diaz-Ajenjo, Rocío Benito, Agustín Rodríguez-Alén, Teresa Sevivas, Thais Murciano, Laura Murillo, Nora V Butta, Nuria Revilla, Rosa Campos, Paola Escribano, Jordi Esteve, Nuria Fernández-Mosteirin, Francisca Ferrer-Marín, Laura Hernández, Jorge Huerta-Aragonés, Antonio León, Mónica López-Duarte, Eugenia López, Mónica Martín-Salces, Meritxell Nomdedeu, Raquel Oña, rene Peláez-Pleguezuelos, Fernando Ramos, Elena Sebastián, Claudia Serrano, Cristina Sierra-Aisa, Rosa Vidal-Laso, José Ramón González-Porras, María Luisa Lozano, José María Bastida, José Rivera
Stay updated on the latest scientific advances in the field of platelet disorders with Hemostasis Today.
-
Aug 12, 2025, 18:44Maxime Dely: Does Whole Blood Deserve a Greater Role in Modern Transfusion Medicine?
-
Aug 12, 2025, 18:19Pall T. Onundarson: The Fiix Test Team Was Awarded UNIVANTS 2025!
-
Aug 12, 2025, 14:35Preventable Blood Clots Take Lives: Arshell Shares Her Daughter Leschel’s Tragic Story to Raise Awareness
-
Aug 12, 2025, 14:16Antonio Ciacciarelli: touchNEUROLOGY Future Leader 2025
-
Aug 12, 2025, 06:39Join an NHLBI Clinical Trial on Blood Clots, Inflammation, and Vascular Disease
-
Aug 12, 2025, 17:40Lina Khider: Venous Recanalization of Chronic DVTs Cures Post-Thrombotic Syndrome!
-
Aug 12, 2025, 11:08A Rare Case of Aortic Thrombosis in a Newborn With CDH
-
Aug 12, 2025, 03:37Low-Intensity DOACs in VTE: Sapienza University Reports Long-Term Outcomes
-
Aug 12, 2025, 02:00Arsene Mekinian։ International Vexas' Announcements Is Finally Published
-
Aug 12, 2025, 01:27Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism